standing for intermediate, and micropapillary and solid representing worse prognosis. The clinicopathological diagnosis of LUAD reports the percentage of all types in increments of 5%. Thus, we evaluated the histological subtype of the IHC results and reported the percentage of all identifiable patterns in 5% increments. This classification indicated ZDHHC5 protein expression varied within different histological subtypes, which further supported the heterogeneity of the growth patterns among LUAD. However, the IHC data was not sufficient for statistical analysis.
